March 23, 2020 Ted White Chief Executive Officer Verrica Pharmaceuticals Inc. 10 North High Street, Suite 200 West Chester, PA 19380 Re: Verrica Pharmaceuticals Inc. Registration Statement on Form S-3 Filed March 13, 2020 File No. 333-237171 Dear Mr. White: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Darren K. DeStefano, Esq.